Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy
- 1 November 1992
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 37 (5) , 453-459
- https://doi.org/10.1111/j.1365-2265.1992.tb02358.x
Abstract
OBJECTIVE We assessed the effects of the administration of low dose growth hormone in growth hormone deficient adults on body composition and physical performance. We compared the validity of different measures of body composition in GH treated adults. DESIGN An uncontrolled longitudinal study of eight patients with GH deficiency who were treated with 4 units of biosynthetic growth hormone (Norditropin), three times a week. Subjects were studied for 8 weeks. PATIENTS Eight patients with acquired growth hormone deficiency as defined by <5mU/1 GH following standard provocative investigations in whom other hormone replacement was optimized. MEASUREMENTS IGF‐I was measured on day 1 and after 4 and 8 weeks of treatment with recombinant human growth hormone. Body composition was estimated by dual energy X‐ray absorptiometry, bioelectrical impedance, skinfold anthropometry, total body potassium measurement and by computerized tomography of a representative cross‐sectional area of thigh on day 1 and following 8 weeks of treatment. Exercise capacity was measured on an electromechanical bicycle and palmar grip strength was measured using a Jamar dynamometer on day 1 and after 8 weeks. RESULTS IGF‐I increased significantly. Exercise capacity and maximum heart rate achieved on the electromechanical bicycle increased significantly. Grip strength did not change. There was a significant increase in fat‐free mass and a decline in fat mass as shown by dual energy X‐ray absorptiometry and bioelectrical impedance. However, this was not confirmed by other methods. No side‐effects were noted. CONCLUSIONS This study shows that a low dose of biosynthetic growth hormone can elevate IGF‐I levels and have a pronounced physical impact in the growth hormone deficient adult without the side‐effects seen at higher dosage schedules. Over a 2 month period the increase in fat‐free mass may be due to an increase in total body water; however, the decline in fat mass is a genuine effect.Keywords
This publication has 21 references indexed in Scilit:
- Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strengthJournal of Applied Physiology, 1991
- Comunicazioni ai SociJournal of Endocrinological Investigation, 1991
- Premature mortality due to cardiovascular disease in hypopituitarismThe Lancet, 1990
- The International Reference Reagent for Insulin-like Growth Factor-IJournal of Endocrinology, 1990
- BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTSThe Lancet, 1989
- Estimation of Non-Fat Body Tissues from Measurements of Skinfold Thickness, total Body Potassium and Total Body NitrogenClinical Science, 1983
- Pitfalls in the Somatomedin-C Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1982
- Effects of Growth Hormone in OsteoporosisJournal of Clinical Endocrinology & Metabolism, 1976
- Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 YearsBritish Journal of Nutrition, 1974
- Relationship between total body water and surface area in normal and obese subjectsJournal of Clinical Pathology, 1971